Nektar Therapeutics (NKTR)
NASDAQ·Healthcare·Biotechnology
$61.01
+1.23%
Mkt Cap $1.16B
Analyst Ratings
Buy
9
Hold
2
Sell
0
Price Target (14 analysts)
$132.83
Range $95.00 – $185.00
Implied Upside
+117.7%
Consensus $132.83 vs current $61.01
NASDAQ·Healthcare·Biotechnology
$61.01
+1.23%
Mkt Cap $1.16B
Buy
9
Hold
2
Sell
0
Price Target (14 analysts)
$132.83
Range $95.00 – $185.00
+117.7%
Consensus $132.83 vs current $61.01